Vanda Pharmaceuticals Inc. - Common Stock (VNDA)

CUSIP: 921659108

Q1 2015 13F Holders as of 31 Mar 2015

Type / Class
Equity / Common Stock
Shares outstanding
59,119,327
Total 13F shares
46,293,079
Share change
-1,267,633
Total reported value
$430,514,637
Put/Call ratio
8.8%
Price per share
$9.30
Number of holders
108
Value change
-$27,508,593
Number of buys
64
Number of sells
51

Sponsored

Quarterly Holders Quick Answers

What is CUSIP 921659108?
CUSIP 921659108 identifies VNDA - Vanda Pharmaceuticals Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Top shareholders of VNDA - Vanda Pharmaceuticals Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
FMR LLC
13F
Company
8.5%
5,046,196
$72,262,000 31 Dec 2014
13F
PRICE T ROWE ASSOCIATES INC /MD/
13F
Company
7.7%
4,575,221
$65,517,000 31 Dec 2014
13F
BAKER BROS. ADVISORS LP
13F
Company
7.6%
4,472,153
$64,041,000 31 Dec 2014
13F
DEERFIELD MANAGEMENT COMPANY, L.P.
13F
Company
7%
4,139,787
$59,282,000 31 Dec 2014
13F
Palo Alto Investors LP
13F
Company
6.4%
3,786,908
$54,229,000 31 Dec 2014
13F
PAULSON & CO. INC.
13F
Company
6.1%
3,625,000
$51,910,000 31 Dec 2014
13F
KINGDON CAPITAL MANAGEMENT, L.L.C.
13F
Company
4.2%
2,461,305
$35,246,000 31 Dec 2014
13F
STATE STREET CORP
13F
Company
3.2%
1,877,584
$26,888,000 31 Dec 2014
13F
BlackRock Fund Advisors
13F
Company
2.6%
1,553,289
$22,243,000 31 Dec 2014
13F
MORGAN STANLEY
13F
Company
2.5%
1,457,718
$20,874,000 31 Dec 2014
13F
VANGUARD GROUP INC
13F
Company
2%
1,180,527
$16,905,000 31 Dec 2014
13F
BlackRock Institutional Trust Company, N.A.
13F
Company
1.9%
1,137,570
$16,290,000 31 Dec 2014
13F
Invesco Ltd.
13F
Company
1.7%
1,022,178
$14,638,000 31 Dec 2014
13F
Signpost Capital Advisors, LP
13F
Company
1.4%
828,793
$11,868,000 31 Dec 2014
13F
MILLENNIUM MANAGEMENT LLC
13F
Company
1.4%
812,770
$11,639,000 31 Dec 2014
13F
ARMISTICE CAPITAL, LLC
13F
Company
1.2%
728,000
$10,425,000 31 Dec 2014
13F
WALL STREET ASSOCIATES
13F
Company
1.1%
655,800
$9,391,000 31 Dec 2014
13F
TIAA CREF INVESTMENT MANAGEMENT LLC
13F
Company
0.85%
503,695
$7,213,000 31 Dec 2014
13F
RTW INVESTMENTS, LP
13F
Company
0.85%
500,000
$7,160,000 31 Dec 2014
13F
NORTHERN TRUST CORP
13F
Company
0.76%
447,798
$6,412,000 31 Dec 2014
13F
ADAGE CAPITAL PARTNERS GP, L.L.C.
13F
Company
0.63%
375,000
$5,370,000 31 Dec 2014
13F
D. E. Shaw & Co., Inc.
13F
Company
0.62%
369,271
$5,288,000 31 Dec 2014
13F
SPHERA FUNDS MANAGEMENT LTD.
13F
Company
0.62%
368,390
$5,275,000 31 Dec 2014
13F
OXFORD ASSET MANAGEMENT LLP
13F
Company
0.58%
340,287
$4,951,000 31 Dec 2014
13F
NEXT CENTURY GROWTH INVESTORS LLC
13F
Company
0.57%
338,102
$4,841,000 31 Dec 2014
13F
Alyeska Investment Group, L.P.
13F
Company
0.47%
280,000
$4,010,000 31 Dec 2014
13F
J. Goldman & Co LP
13F
Company
0.47%
277,173
$3,969,000 31 Dec 2014
13F
DEUTSCHE BANK AG\
13F
Company
0.43%
256,398
$3,670,000 31 Dec 2014
13F
BARCLAYS PLC
13F
Company
0.4%
236,152
$3,306,000 31 Dec 2014
13F
First Light Asset Management, LLC
13F
Company
0.39%
229,818
$3,291,000 31 Dec 2014
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.37%
221,105
$3,166,000 31 Dec 2014
13F
Bank of New York Mellon Corp
13F
Company
0.36%
213,895
$3,063,000 31 Dec 2014
13F
CREDIT AGRICOLE S A
13F
Individual
0.36%
212,184
$2,960,000 31 Dec 2014
13F
PRINCIPAL FINANCIAL GROUP INC
13F
Company
0.32%
188,500
$2,699,000 31 Dec 2014
13F
GOLDMAN SACHS GROUP INC
13F
Company
0.3%
178,643
$2,558,000 31 Dec 2014
13F
Forward Management, LLC
13F
Company
0.29%
172,300
$2,196,000 31 Dec 2014
13F
TD ASSET MANAGEMENT INC
13F
Company
0.24%
139,600
$1,999,000 31 Dec 2014
13F
AMERIPRISE FINANCIAL INC
13F
Company
0.23%
134,194
$1,922,000 31 Dec 2014
13F
MACQUARIE GROUP LTD
13F
Company
0.22%
130,000
$1,862,000 31 Dec 2014
13F
BlackRock Investment Management, LLC
13F
Company
0.19%
113,210
$1,621,000 31 Dec 2014
13F
QS Investors, LLC
13F
Company
0.19%
110,486
$1,583,000 31 Dec 2014
13F
WELLINGTON MANAGEMENT GROUP LLP
13F
Company
0.17%
99,010
$1,418,000 31 Dec 2014
13F
GILDER GAGNON HOWE & CO LLC
13F
Company
0.14%
84,613
$1,212,000 31 Dec 2014
13F
CITADEL ADVISORS LLC
13F
Company
0.14%
81,677
$1,170,000 31 Dec 2014
13F
BRIDGEWAY CAPITAL MANAGEMENT, LLC
13F
Company
0.14%
80,000
$1,146,000 31 Dec 2014
13F
CREDIT SUISSE AG/
13F
Company
0.13%
79,044
$1,132,000 31 Dec 2014
13F
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
13F
Company
0.12%
73,842
$1,057,000 31 Dec 2014
13F
JW Asset Management, LLC
13F
Company
0.11%
67,746
$971,000 31 Dec 2014
13F
GAGNON SECURITIES LLC
13F
Company
0.11%
66,367
$950,000 31 Dec 2014
13F
CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM
13F
Company
0.12%
73,700
$879,000 31 Dec 2014
13F

Institutional Holders of Vanda Pharmaceuticals Inc. - Common Stock (VNDA) as of Q1 2015

As of 31 Mar 2015, Vanda Pharmaceuticals Inc. - Common Stock (VNDA) was held by 108 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 46,293,079 shares. The largest 10 holders included GOLDMAN SACHS GROUP INC, DEERFIELD MANAGEMENT CO, PAULSON & CO. INC., Palo Alto Investors, LLC, FMR LLC, STATE STREET CORP, ARMISTICE CAPITAL, LLC, KINGDON CAPITAL MANAGEMENT, L.L.C., BAKER BROS. ADVISORS LP, and MILLENNIUM MANAGEMENT LLC. This page lists 108 institutional shareholders reporting positions in this security for the Q1 2015 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q1 2015 vs Q4 2014 Across Filers

Q4 2014 holders
108
Q1 2015 holders
108
Holder diff
0
Investor Q4 2014 Shares Q1 2015 Shares Share Diff Share Chg % Q4 2014 Value $ Q1 2015 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.